Fragment screening at adenosine-A3 receptors in living cells using a fluorescence-based binding assay

Chemistry and Biology

Volumn 19, Issue 9, 2012, Pages 1105-1115

  Stoddart, Leigh A ^a   Vernall, Andrea J ^a   Denman, Jessica L ^a   Briddon, Stephen J ^a   Kellam, Barrie ^a   Hill, Stephen J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR ANTAGONIST; CA200645; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HIGH THROUGHPUT SCREENING; MEDICAL TECHNOLOGY; MOLECULAR LIBRARY; MOLECULAR WEIGHT; NONHUMAN; RECEPTOR BINDING; STEREOCHEMISTRY; VALIDATION PROCESS;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENCE; HUMANS; LIGANDS; LUMINESCENT MEASUREMENTS; MICROSCOPY, CONFOCAL; MOLECULAR STRUCTURE; PROTEIN BINDING; RECEPTOR, ADENOSINE A3; SMALL MOLECULE LIBRARIES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84866724912     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2012.07.014     Document Type: Article

References (42)

1. M. Azzi, P.G. Charest, S. Angers, G. Rousseau, T. Kohout, M. Bouvier, and G. Piñeyro β-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors Proc. Natl. Acad. Sci. USA 100 2003 11406 11411 (Pubitemid 37205948)
2. J.G. Baker, and S.J. Hill Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates Trends Pharmacol. Sci. 28 2007 374 381 (Pubitemid 47087964)
3. 2)-adrenoceptor Br. J. Pharmacol. 137 2002 400 408
4. 2-adrenoceptor provide evidence for agonist-directed signalling Mol. Pharm. 64 2003 1357 1369 (Pubitemid 37532226)
5. S. Bartoli, C.I. Fincham, and D. Fattori The fragment-approach: an update Drug Discov. Today. Technol. 3 2006 425 431 (Pubitemid 46158389)
6. 1-adenosine receptor-antagonist complexes in single living cells Proc. Natl. Acad. Sci. USA 101 2004 4673 4678 (Pubitemid 38437469)
7. 2- adrenergic G protein-coupled receptor Science 318 2007 1258 1265 (Pubitemid 350172884)
8. 3 selective antagonist Science 330 2010 1091 1095
9. 2 adrenergic receptor Nature 477 2011 611 615
10. 3-receptors in rat cerebral cortical membranes Br. J. Pharmacol. 114 1995 357 362
11. M. Congreve, R.L. Rich, D.G. Myszka, F. Figaroa, G. Siegal, and F.H. Marshall Fragment screening of stabilized G-protein-coupled receptors using biophysical methods Methods Enzymol. 493 2011 115 136
12. 1 receptor: Evidence for signaling pathway-dependent changes in agonist potency and relative intrinsic activity Mol. Pharm. 58 2000 1075 1084
13. 3 adenosine receptors exist within heterogeneous complexes in membrane microdomains of individual living cells FASEB J. 22 2008 850 860 (Pubitemid 351350620)
14. 1 adenosine receptor antagonists with stimulant activity on human colon motility ChemMedChem 6 2011 1909 1918
15. C.J. Daly, R.A. Ross, J. Whyte, C.M. Henstridge, A.J. Irving, and J.C. McGrath Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and 'cannabinoid-like' receptors in small arteries Br. J. Pharmacol. 159 2010 787 796
16. 1) receptor J. Med. Chem. 54 2011 8195 8206
17. B.B. Fredholm, A.P. IJzerman, K.A. Jacobson, J. Linden, and C.E. Müller International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors - an update Pharmacol. Rev. 63 2011 1 34
18. M.A. Hanson, C.B. Roth, E. Jo, M.T. Griffith, F.L. Scott, G. Reinhart, H. Desale, B. Clemons, S.M. Cahalan, and S.C. Schuerer Crystal structure of a lipid G protein-coupled receptor Science 335 2012 851 855
19. A.L. Hopkins, C.R. Groom, and A. Alex Ligand efficiency: a useful metric for lead selection Drug Discov. Today 9 2004 430 431 (Pubitemid 38510559)
20. E.C. Hulme, and M.A. Trevethick Ligand binding assays at equilibrium: validation and interpretation Br. J. Pharmacol. 161 2010 1219 1237
21. 2A adenosine receptor bound to an antagonist Science 322 2008 1211 1217
22. 3 receptor antagonists Bioorg. Med. Chem. 12 2004 613 623 (Pubitemid 38111172)
23. T. Kenakin, and L.J. Miller Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery Pharmacol. Rev. 62 2010 265 304
24. T.P. Kenakin Biased signaling and allosteric machines; new vistas and challenges for drug discovery Br. J. Pharmacol. 165 2012 1659 1669
25. L.E. Kilpatrick, S.J. Briddon, S.J. Hill, and N.D. Holliday Quantitative analysis of neuropeptide Y receptor association with β-arrestin2 measured by bimolecular fluorescence complementation Br. J. Pharmacol. 160 2010 892 906
26. 2-adrenergic receptor ligands Proc. Natl. Acad. Sci. USA 106 2009 6843 6848
27. 3 adenosine receptor antagonists. synthesis, pharmacological evaluation, and ligand-receptor modeling studies J. Med. Chem. 49 2006 3916 3925 (Pubitemid 43967888)
28. L.T. May, T.J. Self, S.J. Briddon, and S.J. Hill The effect of allosteric modulators on the kinetics of agonist-G protein-coupled receptor interactions in single living cells Mol. Pharmacol. 78 2010 511 523
29. 3 receptor homodimers: quantification using single-cell ligand-binding kinetics FASEB J. 25 2011 3465 3476
30. R.J. Middleton, and B. Kellam Fluorophore-tagged GPCR ligands Curr. Opin. Chem. Biol. 9 2005 517 525 (Pubitemid 41338206)
31. 3 antagonists Chem. Pharm. Bull. (Tokyo) 56 2008 1126 1137
32. S.G.F. Rasmussen, B.T. DeVree, Y. Zou, A.C. Kruse, K.Y. Chung, T.S. Kobilka, F.S. Thian, P.S. Chae, E. Pardon, and D. Calinski Crystal structure of the β2 adrenergic receptor-Gs protein complex Nature 477 2011 549 555
33. 1 receptor complex with doxepin Nature 475 2011 65 70
34. J. Steyaert, and B.K. Kobilka Nanobody stabilization of G protein-coupled receptor conformational states Curr. Opin. Struct. Biol. 21 2011 567 572
35. 2 adrenoceptor. Kinetic evidence for intermediate conformational states J. Biol. Chem. 279 2004 686 691 (Pubitemid 38044873)
36. J.E. van Muijlwijk-Koezen, H. Timmerman, R.C. Vollinga, J. Frijtag von Drabbe Künzel, M. de Groote, S. Visser, and A.P. IJzerman Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists J. Med. Chem. 44 2001 749 762 (Pubitemid 32171671)
37. 3 adenosine receptors Mol. Pharm. 57 2000 968 975 (Pubitemid 30253381)
38. E.J. Whalen, S. Rajagopal, and R.J. Lefkowitz Therapeutic potential of β-arrestin- and G protein-biased agonists Trends Mol. Med. 17 2011 126 139
39. M. Whittaker, R.J. Law, O. Ichihara, T. Hesterkamp, and D. Hallett Fragments: past, present and future Drug Discov. Today. Technol. 7 2010 e163 e171
40. C. Williams, and S.J. Hill GPCR signaling: understanding the pathway to successful drug discovery Methods Mol. Biol. 552 2009 39 50
41. 3 adenosine receptor antagonists J. Med. Chem. 54 2011 457 471
42. J.M. Zwier, T. Roux, M. Cottet, T. Durroux, S. Douzon, S. Bdioui, N. Gregor, E. Bourrier, N. Oueslati, and L. Nicolas A fluorescent ligand-binding alternative using Tag-lite® technology J. Biomol. Screen. 15 2010 1248 1259